AI chatbot interaction improves patient perceptions of pharmacist roles in a pilot study
This pilot randomized controlled trial involved 280 participants recruited via a crowdsourcing platform. The intervention group engaged with an AI chatbot (ChatGPT4-o) programmed with identical information to video content, while the comparator group received baseline control educational videos. Follow-up duration was not reported.
Significant differences emerged across treatment groups regarding willingness to seek pharmacist information, comfort asking questions, and awareness of medication monitoring. Perceptions improved in the AI chatbot group compared to controls, but absolute numbers and p-values were not reported. Sentiment analysis showed predominantly neutral or positive interactions, with neutral interactions occurring in n=252, positive in n=95, and few negative interactions.
Participants preferred detailed wh questions over yes/no questions, with wh questions recorded in n=170 and yes/no questions in n=103. Engagement depth positively correlated with improved perceptions, where deeper interaction led to better understanding. Safety data were not reported, and no adverse events or discontinuations were documented.
Limitations include the pilot study design and the crowdsourcing platform setup. Funding or conflicts of interest were not reported. AI-powered chatbots can serve as valuable supplements to traditional patient education, but implementation should focus on interfaces that encourage active participation. AI chatbots complement rather than replace human pharmacist interactions.